Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
Clinical trial NCT04708210 · UNKNOWN
Trial details
- NCT number
- NCT04708210
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2022-12-21
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.